reports
N2OFF: Save Foods Received first order from a Peruvian Customer for it...
N2OFF: Save Foods Received first order from a Peruvian Customer for its Eco-Friendly Solution for Fruits and Vegetables Neve Yarak, Israel, May 01, 2024 (GLOBE NEWSWIRE) -- \ (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant-based food, announced today that its subsidiary Save Foods Ltd. received its first purchase order from a customer in Peru, a leading grower, packer and distributor of avocado. Save Foods’ eco- friendly solutions can be applied as a near and post-harvest solution for fresh pro...
Altamira Therapeutics Announces Filing of Provisional Patent Applicati...
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 / Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, toda...
DatChat to Participate in Upcoming EF Hutton Annual Global Conference ...
DatChat to Participate in Upcoming EF Hutton Annual Global Conference on May 15th in New York City Plans to Introduce the Myseum Media Archiving & Social Networking Platform New Brunswick, NJ, May 01, 2024 (GLOBE NEWSWIRE) -- DatChat (Nasdaq: DATS), a secure messaging, social media, and metaverse company, today announced that it will participate in the EF Hutton Annual Global Conference taking place on May 15th, 2024 at The Plaza Hotel in New York City. “We are excited to attend and present at EF Hutton as it provides a unique platform to engage with industry leaders, share insights, an...
Aileron Therapeutics Announces Pricing of Underwritten Registered Dire...
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million Includes initial funding of approximately $20 million, as well as the potential for additional proceeds of approximately $20 million from exercise of three-year warrants issued in offering AUSTIN, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonar...
Tullow Oil: 1 director
A director at Tullow Oil bought 54,000 shares at 36p and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...
CVC Income & Growth Limited: 1 director
A director at CVC Income & Growth Limited bought 26,709 shares at 112p and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AM...
SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level - The Company Filed IP Protection Related to the ASXL1 Mutation, a Highly Prevalent Gene Mutation in Myeloid Malignancies and Solid Tumors With Significant Market Potential – - 100% Overall Response Rate in Patients with ASXL1 Mutation in the SLS009 30mg BIW Cohort to Date, All Patients Alive: Further Support for Potential Accelerated Approval Pathway in Defined Patient Population – - SLS009 Exhibits Strong Anti-Leukemic Activ...
Hybridan Small Cap Feast - 01 May 2024
1st May 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced Dish of the day Admissions: Delistings: REDX Pharma (REDX.L) has delisted from the AIM Market What’s baking in the oven? ** Potential**** Initial Public Offerings: Reverse Takeovers: 16 April 2024: Electric Guitar (ELEG.L) Concurrent with its Admission to trading on AIM, Electric Guitar is proposing ...
One Stop Systems Announces Annual Meeting of Shareholders
One Stop Systems Announces Annual Meeting of Shareholders ESCONDIDO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (“OSS” or the "Company") (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced that it will host its Annual Meeting of Shareholders, virtually on May 15, 2024, at 11:00 AM PT. Shareholders who owned the Company’s stock as of the close of business on March 22, 2024, can register, vote electronically, and submit questions by using the control number...
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health...
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month The Company is highlighting stories from adolescents with major depressive disorder on the heels of groundbreaking FDA clearance MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is committed to supporting adolescents facing major depressive disorder (MDD). NeuroStar TMS (transcranial magnetic stimulat...
Calian Secures Contract Valued up to $90M for IT and Software Developm...
Calian Secures Contract Valued up to $90M for IT and Software Development Services with General Dynamics Mission Systems– Canada to Support Canadian Army OTTAWA, May 01, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative healthcare, communications, learning and cybersecurity solutions, has been awarded a major new contract valued at up to $90 million. This agreement with General Dynamics Mission Systems–Canada (GDMS-C) will enhance the Canadian Army's capabilities through advanced land command, control, communications, compu...
Novo Nordisk A/S - share repurchase programme
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 1 May 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiated 6 February 2024, Novo Nordisk will repurchas...
Motorsport Games Announces Sale of Traxion
Motorsport Games Announces Sale of Traxion MIAMI, May 01, 2024 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (the “Company” or “Motorsport Games”), a racing game developer, publisher, and esports ecosystem provider of official motorsport racing series throughout the world, is today announcing the sale of its gaming media outlet Traxion to Traxion.GG Ltd, a UK subsidiary of Grid Finder Ltd for $250,000. This strategic decision continues Motorsport Games’ ongoing efforts to streamline operations, reduce operational costs and sell off components not considered core to the future o...
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, ...
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024 MIAMI, FL, May 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced it will host a conference call and audio webcast on Wednesday, May 8, 2024, at 8:00 a.m. ET to discuss its fiscal 2024 second quarter financial results and to provide a business update. The audio webcast will be accessible un...
Runway Growth Finance Corp. Announces Second Quarter Regular Dividend ...
Runway Growth Finance Corp. Announces Second Quarter Regular Dividend of $0.40 and $0.07 Supplemental Distribution MENLO PARK, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that its Board of Directors has declared a second quarter 2024 regular dividend of $0.40 per share. In addition, the Board of Directors declared a supplemental dividend of $0.07 per share, for the second q...
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phas...
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) Low-dose LTI-03 (2.5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both pathological basal-like cells and fibroblasts and increased the expression of a biomarker indicative of epithelial health, suggesting potential therapeutic effect Positive trend was observed in seven of eight IPF biomarkers evaluated Low-dose LTI-03 was well-tolerated, with no safety signal observed Data from Cohort 2 evaluatin...
Inuvo to Host First Quarter 2024 Financial Results Conference Call on ...
Inuvo to Host First Quarter 2024 Financial Results Conference Call on Tuesday, May 7th at 4:15 P.M. ET LITTLE ROCK, Ark., May 01, 2024 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), provider of the first generative artificial intelligence (AI) advertiser solution made specifically for brands and agencies, will host a conference call on Tuesday, May 7, 2024, at 4:15 P.M. Eastern Time to discuss its financial results and provide a business update for the for the first quarter ended March 31, 2024. Conference Call Details: Date: Tuesday, May 7, 2024Time: 4:15 P.M. Eastern Time Toll-...
Voltus GmbH Selects Bridgeline's AI-Powered Site Search
Voltus GmbH Selects Bridgeline's AI-Powered Site Search WOBURN, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing technology software, announced today that Voltus GmbH, a leading German electrical distributor, has selected Bridgeline to power site search for its eCommerce site. Voltus aims to increase online revenue by using Bridgeline’s AI-powered site search for its online catalog of 80,000 products. Bridgeline will increase conversions through features such as autocomplete. A customer can type “cable” and autocomplete will use pas...
Earlyworks Co., Ltd. Reports Financial and Operational Performance for...
Earlyworks Co., Ltd. Reports Financial and Operational Performance for the Six Months Ended October 31, 2023 TOKYO, May 01, 2024 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (NASDAQ: ELWS) (the “Company”), a Japanese provider of blockchain technology solutions, yesterday announced its financial results for the six months ended October 31, 2023. For the six months ended October 31, 2023, the Company’s revenue increased by approximately JPY 22,738 thousand, gross profit increased by approximately JPY 39,631 thousand and net loss decreased by approximately JPY 28,393 thousand, as compared to th...
SIPP Industries Announces Strategic Acquisition of Revenue Share in Ca...
SIPP Industries Announces Strategic Acquisition of Revenue Share in Calypso Pharmaceuticals to Bolster Position in Cannabis and Hemp Industries COSTA MESA, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Sipp Industries, Inc. (OTC: SIPC), a leading player in the cannabis and hemp industries, announces its strategic acquisition of revenue share in Calypso Pharmaceuticals, a Texas-based company renowned for its innovative products and proprietary technology in the cannabis and hemp sectors. The acquisition marks a significant milestone in SIPP Industries' mission to expand its product portfolio an...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.